Sexual Reboot Forum › Choline content in foods
This topic contains 7 replies, has 1 voice, and was last updated by Allen 5 years ago.
September 26, 2013 at 10:18 am #9266
We all know the importance of choline in the sexually exhausted diet, so here is a study conducted by the USDA on the choline content of various foods:
It appears that the raw egg which is so admired on this forum does hold up to the hype.
PS- Hello everyone, i’m new to the forum and suffer from fairly severe se. I look forward to joining the community and offering help so that we can all overcome this self-induced hell on earth.There is another way that you can stop porn addiction, chronic masturbation and recover your sexual health without fighting it with willpower. With the right mindset you won't even relapse. You can learn more about the recovery program hereSeptember 26, 2013 at 10:19 am #9268
Good find. It is nice to see that. I was going to look around myself to try to find some good info.
Welcome aboard ! We have had some success stories in the last little while. Things are looking better than they were a few months ago.September 26, 2013 at 10:19 am #9270
lol yeah thanks for hijacking that pdf file. I gave this to manny a long time ago.September 26, 2013 at 10:20 am #9272
It appears that the raw egg which is so admired on this forum does hold up to the hype.
Thanks for sharing this… I’m not sure what you are referring to as it relates to “up to the hype”… Egg yolks blow away every other food with 634 of Phosphatidylcholine. I never realized how potent those raw egg yolks are!!! I’ve been doing them for 2 weeks and my workouts have been better (~10%) and eyesight improving (floaters diminishing). I have inserted the information on Phosphatidylcholine below.
Phosphatidylcholine is important for normal cellular membrane composition and repair. Phosphatidylcholine is also the major delivery form of the essential nutrient choline. Choline itself is a precursor in the synthesis of the neurotransmitter acetylcholine, the methyl donor betaine and phospholipids, including phosphatidylcholine and sphingomyelin among others. (See the Choline monograph for further discussion.) Phosphatidylcholine is involved in the hepatic export of very-low-density lipoproteins.
MECHANISM OF ACTION
Phosphatidylcholine’s role in the maintenance of cell-membrane integrity is vital to all of the basic biological processes. These are: information flow that occurs within cells from DNA to RNA to proteins; the formation of cellular energy and intracellular communication or signal transduction. Phosphatidylcholine, particularly phosphatidylcholine rich in polyunsaturated fatty acids, has a marked fluidizing effect on cellular membranes. Decreased cell-membrane fluidization and breakdown of cell-membrane integrity, as well as impairment of cell-membrane repair mechanisms, are associated with a number of disorders, including liver disease, neurological diseases, various cancers and cell death.
Phosphatidylcholine is absorbed into the mucosal cells of the small intestine, mainly in the duodenum and upper jejunum, following some digestion by the pancreatic enzyme phospholipase, producing lysophosphatidylcholine (lysolecithin). Reacylation of lysolecithin takes place in the intestinal mucosal cells, reforming phosphatidylcholine, which is then transported by the lymphatics in the form of chylomicrons to the blood. Phosphatidylcholine is transported in the blood in various lipoprotein particles, including very-low-density lipoproteins (VLDL), low-density lipoproteins (LDL) and high-density lipoproteins (HDL); it is then distributed to the various tissues of the body. Some phosphatidylcholine is incorporated into cell membranes.
Phosphatidylcholine is also metabolized to choline, fatty acids and glycerol. The fatty acids and glycerol either get oxidized to produce energy or become involved in lipogenesis. Choline is a precursor of acetylcholine. Serum choline levels peak between 2 to 6 hours after oral intake.
INDICATIONS AND USAGE
Phosphatidylcholine may be indicated to help restore liver function in a number of disorders, including alcoholic fibrosis, and possibly viral hepatitis. It may also be indicated for the treatment of some manic conditions. There is some evidence that Phosphatidylcholine may be useful in the management of Alzheimer’s disease and some other cognitive disorders. A possible future role in cancer therapy is also suggested by recent research. It may also be indicated in some with tardive dyskinesia.
Clinical studies have demonstrated that choline is essential for normal liver function. Phosphatidylcholine is a better delivery form and is also more tolerable than choline. But, in addition, research has shown that phosphatidylcholine, independent of its choline content, has striking hepatoprotective effects. In two animal studies using baboons fed diets high in alcohol, some supplemented with a soy-derived polyunsaturated lecithin (60% phosphatidylcholine) and some unsupplemented, both fibrosis and cirrhosis were largely prevented in the phosphatidylcholine group. Most of the unsupplemented animals in these studies, which continued for up to eight years, developed fibrosis or cirrhosis.
Because these researchers had previously found that choline, equal in amounts contained in the phosphatidylcholine-rich lecithin they subsequently used, had no comparable protective effects on the liver, they concluded that the polyunsaturated phospholipids themselves may have been responsible for the benefits observed.
In vitro studies have shown that these phospholipids increase hepatic collagenase activity and may thus help prevent fibrosis and cirrhosis by encouraging collagen breakdown. Several other mechanisms under investigation may also contribute.
Others have reported similarly encouraging results in animal models. Clearly, human trials are warranted.
In addition, phosphatidylcholine has demonstrated other protective effects in non-alcoholic liver disorders, including protection against various other toxic substances. Its benefits in viral hepatitis were reported some years ago by several different research groups in Europe and elsewhere. In one of these studies, individuals suffering from hepatitis type A and B were given 1.8 grams of phosphatidylcholine daily. Compared with unsupplemented controls, the phosphatidylcholine group enjoyed quicker recoveries, fewer relapses and quicker normalization of liver function tests.
Researchers in Great Britain treated chronic active hepatitis C patients with 3 grams daily of phosphatidylcholine in double-blind fashion. The phosphatidylcholine patients had significantly reduced symptoms, compared with controls. All histologic evidence of the disease disappeared in some cases. These researchers, like others, have hypothesized that phosphatidylcholine’s possible antiviral effects are related to the supplement’s apparent ability to increase cellular membrane fluidity and repair the membranes of liver cells.
Phosphatidylcholine may help some with tardive dyskinesia, a neurological disorder characterized by defective cholinergic nerve activity. Both supplemental choline and phosphatidylcholine were found to reduce the muscular hyperactivity of this disorder by about 50% in some studies. However, one significant trial did not see a beneficial effect.
There is some very preliminary evidence that phosphatidylcholine may help control manic symptoms in some.
There has been hope, for some time, that phosphatidylcholine would demonstrate clear-cut benefits in cognitive disorders, such as age-related memory loss and Alzheimer’s disease. There are a few reports that supplemental choline can improve short-term memory skills and enhance the memories of those who are initial poor learners.
Those with Alzheimer’s disease have a diminished ability to synthesize and/or utilize the neurotransmitter acetylcholine, particularly in those areas of the brain related to memory, thus the hope that supplemental choline/phosphatidylcholine might be of benefit. A few studies have suggested some small benefit in memory restoration, but most have not. Research continues.
Recently it has been suggested that phosphatidylcholine might eventually have some therapeutic role in some cancers. There is no evidence of this to date, but animal studies indicate that deficiencies in choline and phosphatidylcholine may disrupt cell membrane signal transduction in ways that could lead to various cancers. There is ample evidence that liver cancer is promoted in various animals by choline-deficient diets, and it has been shown that excess choline can protect against liver cancer in a mouse model.
Phosphatidylcholine has been used to lower serum cholesterol levels, based on the premise that lecithin cholesterol acyltransferase (LCAT) activity has an important role in the removal of cholesterol from tissues. A few studies have shown reduction in serum cholesterol with phosphatidylcholine intake. The results were quite modest, and most studies have not shown any significant cholesterol-lowering activity.
CONTRAINDICATIONS, PRECAUTIONS, ADVERSE REACTIONS
There are no reported or known contraindications of phosphatidylcholine supplementation.
Those with malabsorption problems may develop diarrhea or steatorrhea when using phosphatidylcholine supplements. Those with the antiphospholipid-antibody syndrome should exercise caution in the use of phosphatidylcholine supplements.
No major side effects have been reported. Mild side effects have been noted occasionally such as nausea, diarrhea and increased salivation in some. This holds for all forms of phosphatidylcholine.
There are no known interactions.
There are no reports of overdosage.
DOSAGE AND ADMINISTRATION
There are several forms of phosphatidylcholine supplements. Typical commercial lecithin supplements contain 20 to 30% phosphatidylcholine. Softgel capsules containing 55% and 90% phosphatidylcholine are available. Liquid concentrates containing 3 grams of phosphatidylcholine per 5 milliliters (one teaspoon) are also available.
Recommended doses range from 3 to 9 grams of phosphatidylcholine daily in divided doses.
Atoba MA, Ayoola EA, Ogunseyinde O. Effects of essential phospholipid choline on the course of acute hepatitis-B infection. Trop Gastroenterol. 1985; 6:96-9.
Buko V, Lukivskaya O, Nikitin V, et al. Hepatic and pancreatic effects of polyenoylphosphatidylcholine in rats with alloxan-induced diabetes. Cell Biochem Funct. 1996; 14:131-137.
Canty DJ, Zeisel SH. Lecithin and choline in human health and disease. Nutr Rev. 1994; 52:327-339.
Cohen BM, Lipinski JF, Altesman RI. Lecithin in the treatment of mania: double-blind, placebo-controlled trials. Am J Psychiatry. 1982; 139:1162-1164.
Gelenberg AJ, Dorer DJ, Wojcik JD, et al. A crossover study of lecithin treatment of tardive dyskinesia. J Clin Psychiatry. 1990; 51:149-153.
Growdon JH, Gelenberg AJ, Doller J, et al. Lecithin can suppress tardive dyskinesia. N Engl J Med. 1978; 298:1029-1030.
Hanin I, Ansell GB, eds. Lecithin. Technological, Biological and Therapeutic Aspects. New York and London: Plenum Press; 1987.
Hirsch MJ, Growdon JH, Wurtman RJ. Relations between dietary choline or lecithin intake, serum choline levels, and various metabolic indices. Metabolism. 1978; 27:953-960.
Jackson IV, Nuttall EA, Ibe IO, Perez-Cruet J. Treatment of tardive dyskinesia with lecithin. Am J Psychiatry. 1979; 136:1458-1460.
Jenkins PJ, Portmann BP, Eddleston AL, Williams R. Use of polyunsaturated phosphatidylcholine in HBsAg negative chronic active hepatitis: results of prospective double-blind controlled trial. Liver. 1982; 2:7-81.
Kosina F, Budka K, Kolouch Z, et al. Essential cholinephospholipids in the treatment of virus hepatitis. Cas Lek Cesk. 1981; 120:957-960.
Lieber CS, Leo MA, Aleynik SI, et al. Alcohol Clin Exp Res. 1997; 21:375-379.
Lieber CS, De Carl LM, Mak KM, et al. Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin. Hepatol. 1990; 12:1390-1398.
Little A, Levy R, Chuaqui-Kidd P, Hand D. A double-blind, placebo-controlled trial of high-dose lecithin in Alzheimer’s disease. J Neur Neurosurg Psych. 1985; 48:736-742.
Visco G. Polyunsaturated phosphatidylcholine in association with vitamin B complex in the treatment of acute viral hepatitis B. results of a randomized double-blind clinical study. Clin Ter. 1985; 114:183-188.
Wurtman RJ, Hefti F, Melamed E. Precursor control of neurotransmitter synthesis. Pharmac Rev. 1981; 32:315-335.
Wurtman RJ, Hirsch MJ, Growdon JH. Lecithin consumption raises serum-free-choline levels. Lancet. 1977; 2(8028):68-69.September 26, 2013 at 10:20 am #9273
there is another important thing i noticed there and that is raw liver has a lower phosphatdeylcholine and overall choline content than the cooked liver. Dessicated liver is a really good option.September 26, 2013 at 10:21 am #9275
how much choline should one take in daily?September 26, 2013 at 10:21 am #9277
It various based on Male or Female and age. Ref URL:
For most males 550mg to 3.5G. Age 19-70+ years
I have been trying 5 yolks a day and cycle my foods 2 weeks on, 1 week off… or you can use the 5 days on 2 days off.
I use strictly the yolk (ie. I extract the embryo as well.)September 26, 2013 at 10:21 am #9279
have you noticed anything from the egg yolk.
You must be logged in to reply to this topic.